Today's Date: August 15, 2022
Test Release special characters in the headline © ® ™ é ñ ü ç î ò   •   LIBERTY Dental Plan of New York Awards 12 Scholarships in Partnership with PENCIL   •   RW&CO. is pleased to launch the THYME MATERNITY collection starting THIS FALL   •   Back to School: Key Facts for Families New to Speech and Language Services   •   Test Release special characters in the headline © ® ™ é ñ ü ç î ò   •   Give Your Wallet a Break with Domino's® 50% Off Pizza Deal   •   Poll: Over Half of Voters of Color Oppose Government Negotiation of Drug Prices Once They Learn About Consequences for Patients   •   Meridian of Michigan and Grace Health "Prescribe" Reading for Young Children   •   Mogul Launches Nationwide Campaign Called “Build Better Boards” to Champion More Diverse Boards   •   New Scholarship for Hawaii Veterans and their Families Now Available   •   BEDTIME DEFENDERZ TO THE RESCUE! SCENTCO, INC. LAUNCHES NEW PLUSH TOYS THAT ARE FIGHTING AT NIGHT, SO KIDS CAN SLEEP TIGHT!   •   Veterans Embody Unique Assets in the Ministry and Should Be Trained Accordingly   •   Greenwood and Travis Hunter Sign NIL Deal and Partner to Launch the “Choose Black” Campaign   •   Mogul Launches Nationwide Campaign Called “Build Better Boards” to Champion More Diverse Boards   •   SUN-MAID® FEEDS IMAGINATIONS WITH YOUTUBE ICON MRBEAST AND BEAST PHILANTHROPY FOR BACK-TO-SCHOOL VIDEO   •   Aura and Blue Star Families expand efforts to reverse disproportionate rate of cybercrime affecting military families   •   Greenwood and Travis Hunter Sign NIL Deal and Partner to Launch the “Choose Black” Campaign   •   LIBERTY Dental Plan of New York Awards 12 Scholarships in Partnership with PENCIL   •   “What I Want to Know with Kevin P. Chavous” Podcast Launches Third Season in Search of Answers to Education’s   •   Five Innovative Women-Led Startups Pitch New Technologies & Products at BMO & 1871's Third Annual WMNfintech Program

Notice: Undefined index: currentSection in /home/blackradionetwork/public_html/page.php on line 176
Bookmark and Share

Blacks Benefiting From Targeted Cancer Therapy

 PHILDALPHIA — African-American patients with non-small cell lung cancer are just as likely to display an epidermal growth factor receptor (EGFR) mutation in tumors as Caucasians, which suggests they are as likely to benefit from targeted therapies such as erlotinib.

“This study has immediate implications for patient management. Patients with EGFR mutations have a much better prognosis and respond better to erlotinib than those who do not,” said Ramsi Haddad, Ph.D., director of the Laboratory of Translational Oncogenomics at the Barbara Ann Karmanos Cancer Institute, and assistant professor at Wayne State University School of Medicine.

Haddad’s study, which he presented at the Fourth AACR International Conference on Molecular Diagnostics in Cancer Therapeutic Development, also showed that African-Americans were more likely to have mutations on exon 19, rather than exon 21, which suggests they would be even more responsive to erlotinib.

Erlotinib, currently marketed as Tarceva by Genentech, has shown remarkable benefits in non-small cell lung cancer patients with EGFR mutations. Other therapies are in development and the genetic testing is clinically available.

Previous studies had suggested that African-Americans had lower rates of EGFR mutation, which researchers had offered as a possible explanation for their generally poorer prognosis.

However, Haddad’s study was larger than previous reports. His research team observed 149 patients with non-small cell lung cancer (NSCLC), including 80 Caucasians and 69 African-Americans.

Using state-of-the-art technology that allowed for simultaneous detection of hundreds of oncogene mutations in clinical samples, they identified EGFR mutations in 20 of these patients, including 12 Caucasians and eight African-Americans. The difference was not statistically significant.

Moreover, 100 percent of the EGFR mutations in African-Americans were in exon 19, compared with only two-thirds of the mutations found in Caucasian patients. 

“It is well-documented that the incidence of lung cancer is higher among African-Americans, particularly men, and that their survival is generally poorer compared to their white counterparts,” said Haddad. “Our data suggest that African-Americans with NSCLC harbor mutations in EGFR at rates similar to whites. Thus, African ancestry should not be a factor when deciding whether to test a tumor for these mutations, as doing so could widen the disparity seen in survival. Physicians treating these patients may want to consider this new information in their treatment decisions.” 

 


STORY TAGS: BLACK , AFRICAN AMERICAN , MINORITY , CIVIL RIGHTS , DISCRIMINATION , RACISM , NAACP , URBAN LEAGUE , RACIAL EQUALITY , BIAS , EQUALITY

Video

White House Live Stream
LIVE VIDEO EVERY SATURDAY
alsharpton Rev. Al Sharpton
9 to 11 am EST
jjackson Rev. Jesse Jackson
10 to noon CST


Video

LIVE BROADCASTS
Sounds Make the News ®
WAOK-Urban
Atlanta - WAOK-Urban
KPFA-Progressive
Berkley / San Francisco - KPFA-Progressive
WVON-Urban
Chicago - WVON-Urban
KJLH - Urban
Los Angeles - KJLH - Urban
WKDM-Mandarin Chinese
New York - WKDM-Mandarin Chinese
WADO-Spanish
New York - WADO-Spanish
WBAI - Progressive
New York - WBAI - Progressive
WOL-Urban
Washington - WOL-Urban

Listen to United Natiosns News